Zobrazeno 1 - 10
of 860
pro vyhledávání: '"Watari, R"'
Autor:
Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.. Electronic address: ryosuke.watari@shionogi.co.jp., Tamura N; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Yoshida S; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Kido Y; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Matsuzaki T; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2871-2878. Date of Electronic Publication: 2024 Jun 15.
Autor:
Kido Y; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: yasuto.kido@shionogi.co.jp., Nanchi I; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: isamu.nanchi@shionogi.co.jp., Matsuzaki T; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: takanobu.matsuzaki@shionogi.co.jp., Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: ryosuke.watari@shionogi.co.jp., Kiyohara H; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: hayato.kiyohara@shionogi.co.jp., Seki N; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: naomi.seki@shionogi.co.jp., Okuda T; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: tomohiko.okuda@shionogi.co.jp.
Publikováno v:
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2024 Jun; Vol. 56, pp. 101008. Date of Electronic Publication: 2024 Mar 11.
Autor:
Nobori H; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: haruaki.nobori@shionogi.co.jp., Baba K; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keiko.baba@shionogi.co.jp., Kuroda T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: takayuki.kuroda@shionogi.co.jp., Baba K; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kaoru.baba@shionogi.co.jp., Matsumoto K; Shionogi TechnoAdvance Research & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: kazumi.matsumoto@shionogi.co.jp., Yoshida S; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: shinpei.yoshida@shionogi.co.jp., Watari R; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: ryosuke.watari@shionogi.co.jp., Tachibana Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: yuki.tachibana@shionogi.co.jp., Kato T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: teruhisa.kato@shionogi.co.jp., Fukao K; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: keita.fukao@shionogi.co.jp.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Apr; Vol. 224, pp. 105852. Date of Electronic Publication: 2024 Feb 28.
Autor:
Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan. Electronic address: ryosuke.watari@shionogi.co.jp., Sawada H; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan., Hashimoto H; Department of ADMET and Analytical Chemistry II, Shionogi TechnoAdvance Research & Co., Ltd, Japan., Kasai Y; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan., Oka R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan., Shimizu R; Clinical Pharmacology & Pharmacokinetics, Shionogi & Co., Ltd, Japan., Matsuzaki T; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Mar; Vol. 113 (3), pp. 798-805. Date of Electronic Publication: 2023 Sep 23.
Publikováno v:
African Journal of Applied Research; Vol. 8 No. 2 (2022); 1-13
Purpose: This study examines soap production’s entrepreneurship potential and profitability as a supplementary business for rural rice farmers in Tanzania to promote their economic independence.Design/ Methodology/ Approach: We randomly sampled and
Publikováno v:
高知大学学術研究報告 自然科学編. 30(12):135-153
Autor:
Dantas GAF; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil; Department of Physical Therapy, Universidade Federal do Delta do Parnaíba, Parnaíba, PI, Brazil. Electronic address: glauko.dantas@ufpi.edu.br., Sacco ICN; Department of Physical Therapy, Speech and Occupational Therapy, School of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil., Ferrari AV; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Matias AB; Department of Physical Therapy, Speech and Occupational Therapy, School of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil., Watari R; Department of Physical Therapy, Speech and Occupational Therapy, School of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil., Oliveira LVM; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Marcon TR; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Fatore JA; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Pott-Junior H; Department of Medicine, Universidade Federal de São Carlos, São Carlos, SP, Brazil., Salvini TF; Department of Physical Therapy, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Publikováno v:
Brazilian journal of physical therapy [Braz J Phys Ther] 2023 Jul-Aug; Vol. 27 (4), pp. 100531. Date of Electronic Publication: 2023 Aug 11.
Autor:
Kuroda T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Nobori H; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Fukao K; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Baba K; Research Area for Drug Candidate Generation II, Shionogi TechnoAdvance Research Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Matsumoto K; Research Area for Drug Candidate Generation II, Shionogi TechnoAdvance Research Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Yoshida S; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Tanaka Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Watari R; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Oka R; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Kasai Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Inoue K; Research Area for Drug Candidate Generation II, Shionogi TechnoAdvance Research Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Kawashima S; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Shimba A; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Hayasaki-Kajiwara Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Tanimura M; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Zhang Q; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Tachibana Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Kato T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan., Shishido T; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Apr 03; Vol. 78 (4), pp. 946-952.
Autor:
Suzuki Y; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Miyazaki T; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Muto H; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Kubara K; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Mukai Y; Drug Discovery Platform, KAN Research Institute, Inc., 6-8-2 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan., Watari R; Medicine Development Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Sato S; Medicine Development Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Kondo K; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Tsukumo SI; Department of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima 770-8503, Japan., Yasutomo K; Department of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima 770-8503, Japan., Ito M; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan., Tsukahara K; hhc Data Creation Center, Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2022 Dec 13; Vol. 30, pp. 226-240. Date of Electronic Publication: 2022 Sep 24.
Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3883df6a9b857b1fe020dcaa348695c3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106365
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106365